Azza S. Awad

1.0k total citations
42 papers, 818 citations indexed

About

Azza S. Awad is a scholar working on Pathology and Forensic Medicine, Pharmacology and Molecular Biology. According to data from OpenAlex, Azza S. Awad has authored 42 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 9 papers in Pharmacology and 8 papers in Molecular Biology. Recurrent topics in Azza S. Awad's work include Drug-Induced Hepatotoxicity and Protection (6 papers), Nigella sativa pharmacological applications (5 papers) and Chemotherapy-induced organ toxicity mitigation (5 papers). Azza S. Awad is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (6 papers), Nigella sativa pharmacological applications (5 papers) and Chemotherapy-induced organ toxicity mitigation (5 papers). Azza S. Awad collaborates with scholars based in Egypt, Saudi Arabia and Qatar. Azza S. Awad's co-authors include Amany El-Sharif, Wesam M. El‐Bakly, Ebtehal El‐Demerdash, Rehab Kamel, Hanan S. El‐Abhar, Ayman A. Soubh, Hala F. Zaki, Ahmed M. El‐Dessouki, Ekram Nemr Abd Al Haleem and Hala O. El‐Mesallamy and has published in prestigious journals such as Brain Research, Biochemical Pharmacology and Life Sciences.

In The Last Decade

Azza S. Awad

39 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Azza S. Awad Egypt 17 199 181 154 132 92 42 818
Manar A. Nader Egypt 18 242 1.2× 183 1.0× 71 0.5× 140 1.1× 88 1.0× 59 905
Abolfazl Khajavi Rad Iran 21 214 1.1× 228 1.3× 154 1.0× 172 1.3× 53 0.6× 79 1.0k
Kapil Suchal India 18 377 1.9× 309 1.7× 250 1.6× 135 1.0× 84 0.9× 28 1.3k
Alaadin Polat Türkiye 20 192 1.0× 134 0.7× 236 1.5× 202 1.5× 52 0.6× 46 1.1k
Salma Malik India 21 381 1.9× 275 1.5× 306 2.0× 168 1.3× 157 1.7× 43 1.4k
Saurabh Bharti India 17 411 2.1× 161 0.9× 114 0.7× 109 0.8× 96 1.0× 26 1.1k
Abdulaziz A. Al‐Yahya Saudi Arabia 16 246 1.2× 159 0.9× 248 1.6× 103 0.8× 48 0.5× 24 903
Tomasz Sozański Poland 19 283 1.4× 76 0.4× 66 0.4× 104 0.8× 95 1.0× 66 1.0k
Nariman M. Gameil Egypt 15 169 0.8× 127 0.7× 84 0.5× 85 0.6× 79 0.9× 25 562
Yu Mi Ha South Korea 17 378 1.9× 126 0.7× 123 0.8× 88 0.7× 53 0.6× 22 783

Countries citing papers authored by Azza S. Awad

Since Specialization
Citations

This map shows the geographic impact of Azza S. Awad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Azza S. Awad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Azza S. Awad more than expected).

Fields of papers citing papers by Azza S. Awad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Azza S. Awad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Azza S. Awad. The network helps show where Azza S. Awad may publish in the future.

Co-authorship network of co-authors of Azza S. Awad

This figure shows the co-authorship network connecting the top 25 collaborators of Azza S. Awad. A scholar is included among the top collaborators of Azza S. Awad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Azza S. Awad. Azza S. Awad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Awad, Azza S., et al.. (2022). Role of Lactoferrin in Treatment of Bile Duct Ligation-Induced Hepatic Fibrosis in Rats: Impact on Inflammation and TGF-β1/Smad2/α SMA Signaling Pathway. Journal of Clinical and Experimental Hepatology. 13(3). 428–436. 2 indexed citations
2.
Awad, Azza S., et al.. (2022). TLR9: A friend or a foe. Life Sciences. 307. 120874–120874. 32 indexed citations
3.
5.
Soubh, Ayman A., et al.. (2021). Further insights for the role of Morin in mRTBI: Implication of non-canonical Wnt/PKC-α and JAK-2/STAT-3 signaling pathways. International Immunopharmacology. 100. 108123–108123. 12 indexed citations
6.
Awad, Azza S., et al.. (2021). Colchicine attenuates renal ischemia-reperfusion-induced liver damage: implication of TLR4/NF-κB, TGF-β, and BAX and Bcl-2 gene expression. Canadian Journal of Physiology and Pharmacology. 100(1). 12–18. 8 indexed citations
7.
Tolba, Mai F., et al.. (2021). Rosuvastatin and low‐dose carvedilol combination protects against isoprenaline‐induced myocardial infarction in rats: Role of PI3K/Akt/Nrf2/HO‐1 signalling. Clinical and Experimental Pharmacology and Physiology. 48(10). 1358–1370. 9 indexed citations
8.
El‐Abhar, Hanan S., et al.. (2021). Prasugrel anti-ischemic effect in rats: Modulation of hippocampal SUMO2/3-IкBα/Ubc9 and SIRT-1/miR-22 trajectories. Toxicology and Applied Pharmacology. 426. 115635–115635. 7 indexed citations
9.
El‐Abhar, Hanan S., et al.. (2021). Epac-1/Rap-1 signaling pathway orchestrates the reno-therapeutic effect of ticagrelor against renal ischemia/reperfusion model. Biomedicine & Pharmacotherapy. 139. 111488–111488. 21 indexed citations
10.
Awad, Azza S., et al.. (2019). NUTRITIONAL EVALUATION OF SOME UNCONVENTIONAL DIETARY ENERGY SOURCES IN RUMINANTS RATIONS. Egyptian Journal of Nutrition and Feeds. 22(3). 453–463. 2 indexed citations
13.
Soubh, Ayman A., et al.. (2017). Mangiferin protects against intestinal ischemia/reperfusion-induced liver injury: Involvement of PPAR-γ, GSK-3β and Wnt/β-catenin pathway. European Journal of Pharmacology. 809. 80–86. 35 indexed citations
14.
El‐Dessouki, Ahmed M., et al.. (2016). Neuroprotective Effects of Simvastatin and Cilostazol in l-Methionine-Induced Vascular Dementia in Rats. Molecular Neurobiology. 54(7). 5074–5084. 29 indexed citations
15.
Darwish, Samar F., Wesam M. El‐Bakly, Reem N. El‐Naga, Azza S. Awad, & Ebtehal El‐Demerdash. (2015). Antifibrotic mechanism of deferoxamine in concanavalin A induced-liver fibrosis: Impact on interferon therapy. Biochemical Pharmacology. 98(1). 231–242. 29 indexed citations
16.
Kamel, Rehab, Engy M. El Morsy, & Azza S. Awad. (2012). Immunomodulatory effect of candesartan on indomethacin-induced gastric ulcer in rats. Immunopharmacology and Immunotoxicology. 34(6). 956–961. 7 indexed citations
17.
Mantawy, Eman M., et al.. (2011). Insights antifibrotic mechanism of methyl palmitate: Impact on nuclear factor kappa B and proinflammatory cytokines. Toxicology and Applied Pharmacology. 258(1). 134–144. 44 indexed citations
18.
Awad, Azza S. & Amany El-Sharif. (2011). Curcumin immune-mediated and anti-apoptotic mechanisms protect against renal ischemia/reperfusion and distant organ induced injuries. International Immunopharmacology. 11(8). 992–996. 72 indexed citations
19.
Awad, Azza S.. (2010). Effect of Combined Treatment With Curcumin and Candesartan on Ischemic Brain Damage in Mice. Journal of Stroke and Cerebrovascular Diseases. 20(6). 541–548. 16 indexed citations
20.
Awad, Azza S.. (2006). Role of AT1 receptors in permeability of the blood–brain barrier in diabetic hypertensive rats. Vascular Pharmacology. 45(3). 141–147. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026